These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23315371)

  • 61. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
    Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
    ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation.
    Khot UN; Mishra M; Yamani MH; Smedira NG; Paganini E; Yeager M; Buda T; McCarthy PM; Young JB; Starling RC
    J Am Coll Cardiol; 2003 Feb; 41(3):381-5. PubMed ID: 12575963
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ventricular assist devices as a bridge-to-transplant improve early post-transplant outcomes in children.
    Davies RR; Haldeman S; McCulloch MA; Pizarro C
    J Heart Lung Transplant; 2014 Jul; 33(7):704-12. PubMed ID: 24709269
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of Durable Continuous-Flow Ventricular Assist Devices in Patients on Immunosuppression.
    Sorabella RA; Han J; Topkara VK; Garan AR; Yuzefpolskaya M; Colombo PC; Takeda K; Naka Y; Takayama H
    ASAIO J; 2018; 64(3):334-337. PubMed ID: 28885380
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Body mass index and outcome after ventricular assist device placement.
    Musci M; Loforte A; Potapov EV; Krabatsch T; Weng Y; Pasic M; Hetzer R
    Ann Thorac Surg; 2008 Oct; 86(4):1236-42. PubMed ID: 18805168
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of ventricular assist device-mediated sensitization in the bridge-to-heart-transplantation patient.
    Kwon MH; Zhang JQ; Schaenman JM; Cadeiras M; Gjertson DW; Krystal CA; Laks H; Ardehali A; Deng MC; Shemin RJ; Reed EF
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1161-6. PubMed ID: 25702320
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Use of ventricular assist device as bridge to simultaneous heart and kidney transplantation in patients with cardiac and renal failure.
    Yanagida R; Czer LS; Ruzza A; Schwarz ER; Simsir SA; Jordan SC; Trento A
    Transplant Proc; 2013; 45(6):2378-83. PubMed ID: 23953551
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ventricular Assist Device Driveline Infections: A Systematic Review.
    Krzelj K; Petricevic M; Gasparovic H; Biocina B; McGiffin D
    Thorac Cardiovasc Surg; 2022 Sep; 70(6):493-504. PubMed ID: 34521143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease.
    Walther CP; Niu J; Winkelmayer WC; Cheema FH; Nair AP; Morgan JA; Fedson SE; Deswal A; Navaneethan SD
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29980520
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparing velour versus silicone interfaces at the driveline exit site of HeartMate II devices: infection rates, histopathology, and ultrastructural aspects.
    McCandless SP; Ledford ID; Mason NO; Alharethi R; Rasmusson BY; Budge D; Stoker SL; Clayson SE; Doty JR; Thomsen GE; Caine WT; Kfoury AG; Reid BB; Miller DV
    Cardiovasc Pathol; 2015; 24(2):71-5. PubMed ID: 25483742
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Driveline angle is crucial for preventing driveline infection in patients with HeartMate II device.
    Matsumoto Y; Fukushima S; Shimahara Y; Yamashita K; Kawamoto N; Kuroda K; Seguchi O; Yanase M; Fukushima N; Shimizu H; Kobayashi J; Fujita T
    J Artif Organs; 2019 Mar; 22(1):37-43. PubMed ID: 30298341
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pediatric Quality of Life while Supported with a Ventricular Assist Device.
    Miller JR; Boston US; Epstein DJ; Henn MC; Lawrance CP; Kallenbach J; Simpson KE; Canter CE; Eghtesady P
    Congenit Heart Dis; 2015; 10(4):E189-96. PubMed ID: 25864509
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Infections in patients after Berlin Heart
    Muñoz P; Valerio M; Vásquez V; Velásquez-Rodríguez J; Sousa I; Zatarain E; Barrio JM; Ruiz M; Cuerpo G; Rodríguez-Abella H; Hortal J; Bouza E;
    Transpl Infect Dis; 2018 Oct; 20(5):e12936. PubMed ID: 29846991
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biofilm formation and migration on ventricular assist device drivelines.
    Qu Y; McGiffin D; Kure C; Ozcelik B; Fraser J; Thissen H; Peleg AY
    J Thorac Cardiovasc Surg; 2020 Feb; 159(2):491-502.e2. PubMed ID: 30955967
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Infection during circulatory support with ventricular assist devices.
    Holman WL; Skinner JL; Waites KB; Benza RL; McGiffin DC; Kirklin JK
    Ann Thorac Surg; 1999 Aug; 68(2):711-6. PubMed ID: 10475476
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure.
    Anand J; Singh SK; Hernández R; Parnis SM; Civitello AB; Cohn WE; Mallidi HR
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):267-75, 278.e1. PubMed ID: 25312232
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Outcomes after implantation of 139 full-support continuous-flow left ventricular assist devices as a bridge to transplantation.
    Sabashnikov A; Mohite PN; Weymann A; Patil NP; Hedger M; Sáez DG; Zych B; Wahlers T; Wippermann J; De Robertis F; Bahrami T; Amrani M; Simon AR; Popov AF
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):e59-66. PubMed ID: 25180072
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial.
    Krabatsch T; Netuka I; Schmitto JD; Zimpfer D; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Damme L; Pya Y
    J Cardiothorac Surg; 2017 Apr; 12(1):23. PubMed ID: 28376837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.